Search research articles
Contact Us
Filters
Showing results (71-80 of 186) with videos related to
Page
of 19
Sort By:
Anticancer Research
|
January 18, 2003
Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices
Elli Ioachim, Antonia Charchanti, Nikolaos Stavropoulos, et al.
European Journal of Gynaecological Oncology
|
December 16, 2004
Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters
A Mitselou, E Ioachim, N Zagorianakou, et al.
The Journal of Pathology
|
November 1, 1994
HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections
E Ioachim-Velogianni, N E Stavropoulos, E Kitsiou, et al.
Pathology, Research and Practice
|
November 1, 1996
p53 expression in hepatocellular carcinoma in Greece. Correlation with epidemiological and histopathological data
A Skopelitou, M Hadjiyannakis, V Alexopoulou, et al.
Medical Hypotheses
|
April 27, 2007
A new concept of melanocytic neoplasia pathogenesis based on the phenotype of common acquired nevi
Anna Batistatou, Aikaterini Zioga, John Panelos, et al.
Experimental Oncology
|
January 1, 2005
Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland
Antigony Mitselou, Dimitrios Peschos, Pavlos Dallas, et al.
Anticancer Research
|
September 2, 1999
Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation
E Ioachim, S Kamina, A Demou, et al.
Pathology, Research and Practice
|
January 13, 2000
Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen
E Ioachim, D Assimakopoulos, D Peschos, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 22, 1999
Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression
V D Malamou-Mitsi, M Syrrou, I Georgiou, et al.
In Vivo (Athens, Greece)
|
November 25, 1998
Immunophenotype, ras oncogenes and p53 onco-suppressor gene in benzo(a)pyrene induced malignant soft tissue tumours in Wistar rats
D G Stefanou, A V Nonni, G Kalpouzos, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 186) with videos related to
Sort By:
Page
of 19
Anticancer Research
|
January 18, 2003
Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices
Elli Ioachim, Antonia Charchanti, Nikolaos Stavropoulos, et al.
European Journal of Gynaecological Oncology
|
December 16, 2004
Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters
A Mitselou, E Ioachim, N Zagorianakou, et al.
The Journal of Pathology
|
November 1, 1994
HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections
E Ioachim-Velogianni, N E Stavropoulos, E Kitsiou, et al.
Pathology, Research and Practice
|
November 1, 1996
p53 expression in hepatocellular carcinoma in Greece. Correlation with epidemiological and histopathological data
A Skopelitou, M Hadjiyannakis, V Alexopoulou, et al.
Medical Hypotheses
|
April 27, 2007
A new concept of melanocytic neoplasia pathogenesis based on the phenotype of common acquired nevi
Anna Batistatou, Aikaterini Zioga, John Panelos, et al.
Experimental Oncology
|
January 1, 2005
Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland
Antigony Mitselou, Dimitrios Peschos, Pavlos Dallas, et al.
Anticancer Research
|
September 2, 1999
Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation
E Ioachim, S Kamina, A Demou, et al.
Pathology, Research and Practice
|
January 13, 2000
Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen
E Ioachim, D Assimakopoulos, D Peschos, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 22, 1999
Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression
V D Malamou-Mitsi, M Syrrou, I Georgiou, et al.
In Vivo (Athens, Greece)
|
November 25, 1998
Immunophenotype, ras oncogenes and p53 onco-suppressor gene in benzo(a)pyrene induced malignant soft tissue tumours in Wistar rats
D G Stefanou, A V Nonni, G Kalpouzos, et al.
Page
of 19